Browse the latest research summaries in the field of immunology for spinal cord injury patients and caregivers.
Showing 521-530 of 730 results
iScience, 2023 • January 20, 2023
This study investigates the metabolic mechanisms underlying artemisinin resistance (ART-R) in Plasmodium falciparum, focusing on the role of PfKelch13 mutations and ring-stage growth arrest. The resea...
KEY FINDING: PfKelch13 mutant parasite lines exhibit reduced susceptibility to DHA and prolonged ring stage.
Fluids and Barriers of the CNS, 2023 • January 1, 2023
This study demonstrates that Tocilizumab, an IL-6R monoclonal antibody, can effectively reduce the expression of IL-6 in macrophages and facilitate TJs restoration of the BSCB after spinal cord injury...
KEY FINDING: Tocilizumab treatment significantly increased the expression of claudin-5 (CLDN5) and zonula occludens-1 (ZO-1) between vascular endothelial cells at 14 and 28 days post-injury.
International Journal of Infectious Diseases, 2023 • January 10, 2023
This study comprehensively analyzed the prevalence, severity, and characteristics of smell and taste alterations (STAs) in patients infected with the SARS-CoV-2 Omicron variant. The findings suggest t...
KEY FINDING: The prevalence of smell and taste alterations did not significantly decrease during the Omicron dominance compared to earlier phases of the pandemic.
Frontiers in Immunology, 2023 • January 5, 2023
Spinal cord injury (SCI) initiates a complex immune response that is critical in determining tissue regeneration and functional outcomes. This response involves various immune cells like astrocytes, n...
KEY FINDING: Astrocytes, while not part of the immune system, play essential roles in the immune response to SCI by recruiting immune cells and secreting immunomodulatory molecules. Reactive astrocytes can be either protective or detrimental.
Stem Cell Research & Therapy, 2023 • January 1, 2023
This study investigates the self-renewal and differentiation potential of hypoimmunogenic human pluripotent stem cells (hPSCs) with modified HLA class I presentation. The results demonstrate that engi...
KEY FINDING: Hypoimmunogenic hPSCs, regardless of HLA molecule expression patterns, maintain normal self-renewal capacity.
AGING, 2023 • February 1, 2023
This study investigated the impact of short-term platelet depletion on Alzheimer's disease neuropathology in APP-PS1 mice. The researchers found that platelet depletion in female APP-PS1 mice augmente...
KEY FINDING: Platelet depletion in APP-PS1 female mice shifted amyloid plaque size distribution towards bigger plaques and increased neuritic dystrophy in the hippocampus.
Frontiers in Immunology, 2023 • January 19, 2023
This study combined bulk RNA-seq and scRNA-seq data to investigate the immune landscape in the subacute phase of spinal cord injury (SCI). The research identified key immune hub genes (B2m, Itgb5, Vav...
KEY FINDING: B2m, Itgb5, and Vav1 were identified as key immune genes in macrophages/microglia during the subacute phase of SCI.
Neural Regeneration Research, 2023 • August 1, 2023
This study demonstrates the positive effects of inhibiting tau expression in the treatment of SCI, showing improved nerve tissue repair and functional recovery. Tau inhibition reduces inflammation, al...
KEY FINDING: Tau inhibition after spinal cord injury down-regulated the levels of inflammatory mediators, including tumor necrosis factor-α, interleukin-6 and interleukin-1β.
The EMBO Journal, 2023 • February 17, 2023
This study identifies IFITM1 as a key repressor of brain metastatic colonization in lung cancer. Loss of IFITM1 promotes brain colonization, while high IFITM1 expression activates microglia and enhanc...
KEY FINDING: Loss of IFITM1 promotes brain colonization of human lung cancer cells, identified through in vivo genome-wide CRISPR-Cas9 screening.
Frontiers in Immunology, 2023 • February 24, 2023
The role of MSCs in the treatment of SCI is promising. MSCs achieve immunosuppression through direct contact with immune cells or paracrine release signalling molecules to reduce the inflammatory respo...
KEY FINDING: MSCs can suppress immunity against inflammation by direct contact with immune cells or paracrine activity, modulating the release of cytokines and growth factors at the injury site.